XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Income Statement [Abstract]        
Revenues
Operating Expenses        
Research and development 2,763,865 3,764,675 8,991,673 11,937,045
General and administrative 4,808,551 3,733,326 12,755,190 11,129,463
Stock-based compensation – general and administrative 3,061,763 1,174,111 9,198,340 3,540,787
Total Operating Expenses 10,634,179 8,672,112 30,945,203 26,607,295
Operating Loss (10,634,179) (8,672,112) (30,945,203) (26,607,295)
Other Income        
Interest income 204,843 336,780 640,686 854,604
Gain on sale of New Jersey net operating losses 2,387,842 3,585,689
Total Other Income 204,843 336,780 3,028,528 4,440,293
Loss before Income Taxes (10,429,336) (8,335,332) (27,916,675) (22,167,002)
Income tax expense 144,000 144,000 432,000 432,000
Net Loss (10,573,336) (8,479,332) (28,348,675) (22,599,002)
Deemed dividend on warrant extension 321,559 321,559
Net Loss Applicable to Common Stockholders $ (10,894,895) $ (8,479,332) $ (28,670,234) $ (22,599,002)
Net Loss Per Share - Basic (in Dollars per share) $ (0.06) $ (0.06) $ (0.17) $ (0.15)
Weighted Average Common Shares Outstanding        
Weighted Average Common Shares Outstanding - Basic (in Shares) 173,856,960 153,775,380 163,947,311 148,746,002